← Leaderboards
Jie Zhang
Boston Medical Center
$1,183,462
Attributed
$1,183,462
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $413.7K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$1,183,462 · 1
By mechanism
R01$1,183,462 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston Medical Center
Same institution · by research overlap
- Noyan Gokce$15,647,950
- Steven C. Borkan$7,441,803
- Zhijun Luo$3,331,949
- Jonathan Michael Gall$127,710
- Titilayo Omolara Ilori$1,194,885
Others in their field
Other Rising Stars on “Absorption”
- Colin Osborne · University Of Texas Med Br Galveston$10,407,745
- Alexander Kolykhalov · Emory University$8,116,465
- Anil Gupta · Scripps Research Institute, The$7,340,144
- Debra Burnin · Sri International$7,194,143
- David Burkhart · Inimmune Corporation$5,907,864
- Moustafa Gabr · Weill Medical Coll Of Cornell Univ$5,835,304
Research focus
AbsorptionAnti-Diabetic DrugsApicalArterioleAttenuatedBlood GlucoseDiabetes MellitusDiabeticDiabetic MouseDiabetic NephropathyExcretory FunctionFda ApprovedFeedbackFluorescence ImagingGenerationsGlomerular Filtration RateGlucoseHyperglycemiaInhibitorInjury To KidneyIn VitroIn VivoJuxtaglomerular ApparatusKidney
Grant awards (3)
Significance of Tubuloglomerular Feedback in SGLT1 and SGLT2 Inhibition in Diabetic Kidney Disease$372,536
R01 · FY2025 · DK · contact PI
Significance of Tubuloglomerular Feedback in SGLT1 and SGLT2 Inhibition in Diabetic Kidney Disease$397,249
R01 · FY2024 · DK · contact PI
Significance of Tubuloglomerular Feedback in SGLT1 and SGLT2 Inhibition in Diabetic Kidney Disease$413,677
R01 · FY2023 · DK · contact PI